| 1 |
Nanomedicine: New Frontiers in Fighting Microbial Infections |
|
|
| Mohammad Reza Mehrabi, Madjid Soltani, Mohsen Chiani, Kaamran Raahemifar, Ali Farhangi |
|
| Nanomaterials. 2023; 13(3): 483 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Equity in clinical trials for HIV-associated cryptococcal meningitis: A systematic review of global representation and inclusion of patients and researchers |
|
|
| David S. Lawrence, Tshepo Leeme, Mosepele Mosepele, Thomas S. Harrison, Janet Seeley, Joseph N. Jarvis, Joseph M. Vinetz |
|
| PLOS Neglected Tropical Diseases. 2021; 15(5): e0009376 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans |
|
|
| Koteswara R Chintalacharuvu, Zlatko A Matolek, Benny Pacheco, Erick M Carriera, David O Beenhouwer |
|
| Medical Mycology. 2021; 59(11): 1085 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) |
|
|
| Markus Ruhnke, Oliver A. Cornely, Martin Schmidt-Hieber, Nael Alakel, Boris Boell, Dieter Buchheidt, Maximilian Christopeit, Justin Hasenkamp, Werner J. Heinz, Marcus Hentrich, Meinolf Karthaus, Michael Koldehoff, Georg Maschmeyer, Jens Panse, Olaf Penack, Jan Schleicher, Daniel Teschner, Andrew John Ullmann, Maria Vehreschild, Marie Lilienfeld-Toal, Florian Weissinger, Stefan Schwartz |
|
| Mycoses. 2020; 63(7): 653 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Treatment for HIV-associated cryptococcal meningitis |
|
|
| Mark W Tenforde, Adrienne E Shapiro, Benjamin Rouse, Joseph N Jarvis, Tianjing Li, Ingrid Eshun-Wilson, Nathan Ford |
|
| Cochrane Database of Systematic Reviews. 2018; 2018(7) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Comparative Effectiveness of Induction Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: A Network Meta-Analysis |
|
|
| J. I. Campbell,S. Kanters,J. E. Bennett,K. Thorlund,A. C. Tsai,E. J. Mills,M. J. Siedner |
|
| Open Forum Infectious Diseases. 2015; 2(1): ofv010 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Isolated cervical cryptococcal lymphadenitis without meningitis in an immunocompetent human immunodeficiency virus-negative child: a rare case report |
|
|
| Annie B. Khyriem,Jeetendra Gurung,Wihiwot Valarie Lyngdoh |
|
| JMM Case Reports. 2014; 1(3) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Access to antifungal medicines in resource-poor countries – Authorsæ reply |
|
|
| Angela Loyse,Harry Thangaraj,Nelesh P Govender,Thomas Harrison,Tihana Bicanic |
|
| The Lancet Infectious Diseases. 2014; 14(5): 371 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Access to antifungal medicines in resource-poor countries |
|
|
| Manoj P Jadhav,Nilima A Kshirsagar |
|
| The Lancet Infectious Diseases. 2014; 14(5): 370 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
How low can you go? Use of low- and standard-dose liposomal amphotericin B for treatment of invasive fungal infections |
|
|
| Zahra Kassamali,Larry H. Danziger,Robert C. Glowacki,David N. Schwartz |
|
| International Journal of Infectious Diseases. 2013; 17(8): e615 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries |
|
|
| Angela Loyse,Harry Thangaraj,Philippa Easterbrook,Nathan Ford,Monika Roy,Tom Chiller,Nelesh Govender,Thomas S Harrison,Tihana Bicanic |
|
| The Lancet Infectious Diseases. 2013; 13(7): 629 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Cryptococcal meningitis: Improving access to essential antifungal medicines in resource-poor countries |
|
|
| Loyse, A. and Thangaraj, H. and Easterbrook, P. and Ford, N. and Roy, M. and Chiller, T. and Govender, N. and Harrison, T.S. and Bicanic, T. |
|
| The Lancet Infectious Diseases. 2013; 13(7): 629-637 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole |
|
|
| Rudramurthy, S.M. and Jatana, M. and Singh, R. and Chakrabarti, A. |
|
| Mycoses. 2013; 56(1): 39-46 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
In vitroantifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole |
|
|
| Shivaprakash M. Rudramurthy,Manu Jatana,Rachna Singh,Arunaloke Chakrabarti |
|
| Mycoses. 2013; 56(1): 39 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
New Insights into HIV/AIDS-Associated Cryptococcosis |
|
|
| Spinello Antinori |
|
| ISRN AIDS. 2013; 2013: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis |
|
|
| Abeer H.A. Mohamed-Ahmed,Stephen Brocchini,Simon L. Croft |
|
| Current Opinion in Infectious Diseases. 2012; 25(6): 695 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis |
|
|
| Mohamed-Ahmed, A.H.A. and Brocchini, S. and Croft, S.L. |
|
| Current Opinion in Infectious Diseases. 2012; 25(6): 695-702 |
|
| [Pubmed] [Google Scholar] |
|
| 18 |
Treatment of cryptococcal meningitis with low-dose amphotericin B and flucytosine |
|
|
| Yan, D. and Huang, J.-R. and Lian, J.-S. and Li, L.-J. |
|
| Chinese Medical Journal. 2012; 125(2): 385-387 |
|
| [Pubmed] [Google Scholar] |
|
| 19 |
Nanomedicine-public health perspective |
|
|
| Kshirsagar, N.A. and Jadhav, M.P. |
|
| Journal of Bionanoscience. 2010; 4(1-2): 14-21 |
|
| [Pubmed] [Google Scholar] |
|
